MYC and diffuse large B-cell lymphoma: Thus, MD-DLBCLs, composed of the c-MYC-driven subsets of DLBCL-NOS and DLBCL/BL, including subsets of the newly defined categories of double-hit and triple-hit DLBCL have been suggested to represent an independent clinically highly relevant diagnostic molecular subtype [119].